Petlife Pharmaceuticals

(OTC) PTLF

Current Price$0.00

Market Cap$22.20K

Since IPO (2011)-100%

5 Year-97%

1 Year+0%

1 Month-1%

Petlife Pharmaceuticals Financials at a Glance

Market Cap

$22.20K

Revenue (TTM)

$0.00

Net Income (TTM)

-$3.71M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

44.43 (High)

Dividend

$0.00

Beta (Volatility)

44.43 (High)

Price

$0.00

Volume

400

Open

$0.00

Price

$0.00

Volume

400

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jul 23, 2012

Dividend

$0.00

Beta (Volatility)

44.43 (High)

Price

$0.00

Volume

400

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jul 23, 2012

PTLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Petlife Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Los Angeles, CA 90046, US

PTLF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

16%

Return on Assets

-423%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$22.20K

Shares Outstanding

222.12M

Volume

400

Avg. Volume

246.25

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$22.66M

EBITDA

-$22.87M

Operating Cash Flow

-$318.92K

Capital Expenditure

$0.00

Free Cash Flow

-$318.92K

Cash & ST Invst.

$54.25K

Total Debt

$717.18K

Petlife Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2018YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$22.20K

N/A

Market Cap/Employee

$22.20K

N/A

Employees

N/A

Net Income

-$427.06K

+67.6%

EBITDA

-$345.03K

+72.5%

Quarterly Fundamentals

Name

Q2 2018YOY CHG

Total Cash

$7.86K

+1665.4%

Total Debt

$801.65K

+99.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$801.65K

+99.6%

Return on Assets

-422.82%

N/A

Return on Invested Capital

16.40%

N/A

Free Cash Flow

-$162.45K

-3.6%

Operating Cash Flow

-$162.45K

-3.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AOLSAeolus Pharmaceuticals, Inc.

AOLSAeolus Pharmaceuticals, Inc.$0.00+0.00%

HCANFHalo Collective Inc.

HCANFHalo Collective Inc.$0.00+0.00%

MPXOFMPX International Corporation

MPXOFMPX International Corporation$0.00+0.00%

MRRCFWayland Group Corp.

MRRCFWayland Group Corp.$0.00+0.00%

FIORFFiore Cannabis Ltd.

FIORFFiore Cannabis Ltd.$0.00+0.00%

CBGIThe CannaBusiness Group, Inc.

CBGIThe CannaBusiness Group, Inc.$0.00+0.00%

LOWLFLowell Farms Inc.

LOWLFLowell Farms Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About PTLF

What is the current price of Petlife Pharmaceuticals?

Petlife Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Petlife Pharmaceuticals?

Over the past 52 weeks, Petlife Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does Petlife Pharmaceuticals have?

Petlife Pharmaceuticals total debt is unavailable.

How much cash does Petlife Pharmaceuticals have on hand?

Petlife Pharmaceuticals does not have cash on hand data available.

What is Petlife Pharmaceuticals’s dividend yield?

Petlife Pharmaceuticals does not currently have a dividend yield.

Petlife Pharmaceuticals

Petlife Pharmaceuticals Financials at a Glance

PTLF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Petlife Pharmaceuticals

PTLF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Petlife Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PTLF

What is the current price of Petlife Pharmaceuticals?

What is the 52-week range for Petlife Pharmaceuticals?

How much debt does Petlife Pharmaceuticals have?

How much cash does Petlife Pharmaceuticals have on hand?

What is Petlife Pharmaceuticals’s dividend yield?

Premium Investing Services